Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Cediranib Maleate in Treating Patients With Recurrent or Metastatic Kidney Cancer That Cannot Be Removed By Surgery [Phase 2]
Phase 2 trial evaluating cediranib in patients with recurrent or metastatic renal cell carcinoma not removable by surgery; study completed a…
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: BEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC) [Phase 1, Phase 2]
A Phase 1/2 clinical trial of BEZ235 (dactolisib) in patients with advanced renal cell carcinoma was terminated, with results posted in Febr…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF [Phase 1, Phase 2]
Phase 1/Phase 2 trial evaluating a dendritic cell tumor fusion vaccine with GM-CSF in renal cell carcinoma; results were posted after comple…
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Assessing Everolimus in Fist Line Treatment on Patients With Metastatic Kidney Cancer [Phase 2]
Phase II trial evaluating everolimus as first-line therapy for metastatic kidney cancer has been terminated. The update notes the study stat…
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients [Phase 4]
Phase 4 trial evaluating CYP3A4 and CYP1A2 phenotyping to tailor Sunitinib or Erlotinib therapy in cancer patients, including non-small cell…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: A Phase 2 Study of ASONEP™ to Treat Unresectable and Refractory Renal Cell Carcinoma [Phase 2]
A Phase 2 trial evaluating ASONEP for unresectable and refractory renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-01-18Clinical Trial Update: PF-04856884 (CVX-060) In Combination With Axitinib In Patients With Previously Treated Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 trial of PF-04856884 (CVX-060) plus axitinib in previously treated metastatic renal cell carcinoma has been terminated; results post…
-
CLINICAL_TRIALS trial_result · 2016-01-13Clinical Trial Update: A Norwegian Observational Trial Evaluating the Treatment of Advanced Renal Cell Cancer Patients Under Treatment of Afinitor
An observational Norwegian trial evaluating treatment with Afinitor (everolimus) in patients with metastatic renal cell carcinoma has been c…
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: Percutaneous Renal Tumor Cryoablation Followed by Biopsy [Phase 1]
A Phase 1 study evaluating percutaneous cryoablation of renal tumors with subsequent biopsy has completed, as reported by Memorial Sloan Ket…
-
CLINICAL_TRIALS trial_result · 2015-12-30Clinical Trial Update: The Detection of Circulating Tumor Cells (CTCs) in Patients With Renal Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment
A completed clinical trial evaluated circulating tumor cell detection in kidney cancer patients treated with cryosurgery plus DC-CIK immunot…
-
CLINICAL_TRIALS trial_result · 2015-12-28Clinical Trial Update: Evaluating Renal Masses Using Ultrasound Intravenous Microbubble Contrast [Phase 1]
A Phase 1 trial evaluating ultrasound intravenous microbubble contrast to characterize renal masses has completed, assessing feasibility and…
-
CLINICAL_TRIALS trial_result · 2015-12-21Clinical Trial Update: Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer [Phase 2]
Phase 2 trial assessing low-intensity stem cell transplantation with multiple lymphocyte infusions for advanced kidney cancer (renal cell ca…
-
CLINICAL_TRIALS trial_result · 2015-12-10Clinical Trial Update: Remote Ischemia Pre-Conditioning in Patients Undergoing Partial Nephrectomy [NA]
The clinical trial evaluating remote ischemia pre-conditioning in patients undergoing partial nephrectomy for renal cell carcinoma was termi…
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Kidney Removal [Phase 2]
Phase 2 trial evaluating pre-operative use of sorafenib in patients with metastatic renal cell carcinoma undergoing nephrectomy has complete…
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma [Phase 1, Phase 2]
ClinicalTrials.gov reports a Phase 1b/2 study of carfilzomib in relapsed solid tumors, multiple myeloma, or lymphoma. The study is completed…
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: A Study of Neoadjuvant Sutent for Patients With Renal Cell Carcinoma [Phase 2]
This clinical trial update indicates that a Phase 2 neoadjuvant study of Sutent (sunitinib) for renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-12-07Clinical Trial Update: A Feasibility Study for a Multicentre Randomised Controlled Trial to Compare Surgery With Needle Ablation Techniques in People With Small Renal Masses (4cm) [NA]
This completed feasibility multicenter randomized trial compared surgery with needle ablation techniques for small renal masses (4 cm).
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors [Phase 1]
Phase 1 safety study of recombinant vaccinia virus JX-594 for refractory solid tumors completed, evaluating melanoma, lung cancer, renal cel…
-
CLINICAL_TRIALS trial_result · 2015-12-01Clinical Trial Update: Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients [Phase 2]
Phase 2 trial update evaluating bevacizumab with an autologous tumor/dendritic cell vaccine plus interleukin-2 and interferon alfa-2b in met…
-
CLINICAL_TRIALS trial_result · 2015-12-01Clinical Trial Update: Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response [Phase 1]
This Phase 1 trial of Sunitinib in metastatic renal cell carcinoma evaluated imaging biomarkers to predict early tumor response during thera…
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial evaluating sunitinib for locally recurrent or metastatic kidney cancer. The study has completed and posted results in…
-
CLINICAL_TRIALS trial_result · 2015-11-24Clinical Trial Update: Vorinostat and Isotretinoin in Treating Patients With Advanced Kidney Cancer [Phase 1, Phase 2]
Phase 1/2 trial of vorinostat and isotretinoin in advanced kidney cancer (recurrent/stage III/IV renal cell cancer) has been terminated with…
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC) [Phase 1]
A Phase 1 study evaluating the combination of sunitinib and temsirolimus in renal cell carcinoma has been completed.
-
CLINICAL_TRIALS trial_result · 2015-11-06Clinical Trial Update: Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma [Phase 3]
A phase 3 trial comparing dovitinib with sorafenib in metastatic renal cell carcinoma has completed, with results posted in November 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-06Clinical Trial Update: Bioequivalence Study of Sorafenib Tablet and Nexavar [Phase 1]
A Phase 1 bioequivalence study comparing sorafenib tablet to Nexavar under fasting conditions has completed.